FARMARUBICIN 10MG/5ML INJECTION 2 mg/ml Solution for injection Vial

Product Overview

FARMARUBICIN 10MG/5ML INJECTION is a potent antineoplastic agent used in the treatment of various cancers.

This solution for injection, containing Epirubicin Hydrochloride at a concentration of 2 mg/ml, is designed for intravenous administration.

As referenced on NahdiOnline, , and , Farmarubicin is a key medication in oncology.

For optimal results, always consult a healthcare professional before use.

Key Benefits of Use

• Effective in treating a wide range of cancers, including breast cancer, ovarian cancer, stomach cancer, and lung cancer.
• Works by interfering with the growth and spread of cancer cells.
• Often used as part of a multi-drug chemotherapy regimen to maximize therapeutic effect.
• Contributes to disease remission and improved patient outcomes in suitable cases.

How to Use

FARMARUBICIN 10MG/5ML INJECTION must be administered under the direct supervision of a qualified healthcare professional experienced in the use of cytotoxic agents.

1. The dosage and administration schedule are carefully determined by the treating physician based on the specific type and stage of cancer, the patient's body surface area, and overall health status.
2. It is administered via intravenous infusion, ensuring slow and controlled delivery into the bloodstream.
3. Patients typically receive pre-medication to manage potential side effects such as nausea and vomiting.
4. During and after administration, patients are closely monitored for adverse reactions and bone marrow function.
5. Strict aseptic techniques must be followed during preparation and administration to prevent contamination.

Caution & Warnings

• Cardiotoxicity:

  Epirubicin can cause dose-dependent cardiac toxicity, including congestive heart failure. Regular monitoring of cardiac function (e.g., ECG, echocardiogram) is essential before and during treatment.

• Myelosuppression:

  This medication commonly causes bone marrow suppression, leading to reduced white blood cell, red blood cell, and platelet counts. This increases the risk of serious infections, anemia, and bleeding. Complete blood counts must be monitored frequently.

• Extravasation:

  If the injection leaks outside the vein, it can cause severe tissue damage, necrosis, and blistering. Immediate action must be taken if extravasation occurs.

• Gastrointestinal Effects:

  Common side effects include nausea, vomiting, mucositis (inflammation of mucous membranes), and diarrhea. Anti-emetic prophylaxis is usually recommended.

• Hair Loss:

  Reversible alopecia is a common side effect.

• Pregnancy and Lactation:

  Epirubicin is contraindicated during pregnancy and breastfeeding due to potential harm to the fetus or infant. Women of childbearing potential and men should use effective contraception during and for a period after treatment.

• Liver and Kidney Impairment:

  Dosage adjustments may be necessary in patients with impaired liver or kidney function.

Ingredients

• Active Ingredient: Epirubicin Hydrochloride (10 mg per 5 ml vial)
• Excipients: Sodium Chloride, Water for Injections, Hydrochloric Acid (for pH adjustment).

Product Details

• Form: Solution for injection
• Strength: 10 mg / 5 ml (2 mg/ml)
• Package Type: Vial
• Manufacturer: Pfizer
• Drug Type: Prescription Only Medicine (POM)
• Storage: Store refrigerated (2°C to 8°C) and protect from light.